Injectafer lawsuits allege serious side effects after taking this drug. If you were injured after taking Injectafer, you may be entitled to compensation for your medical bills, lost wages and pain and suffering, among other losses. For a free (no obligation) case evaluation, call our toll-free number 24/7 at 1-800-992-6878 or fill out an online contact form.
What is Injectafer?
Injectafer (ferric carboxymaltose) is an injectable drug used for patients who have iron deficiency anemia (IDA) and cannot take iron supplements orally. It is also used in patients who have chronic kidney disease but are not on dialysis. The injection releases iron directly into the bloodstream to reduce the side effects on IDA. Iron is important to the body because it aids in the production of hemoglobin, which transports oxygen throughout the body. Injectafer was approved by the FDA on July 26, 2013, and was a first of its kind to be introduced. However, shortly after its approval, studies were conducted to show serious side effects that occurred after taking this drug.
What Are The Potential Dangers of Injectafer?
According to a study in 2015, more than half of the patients injected with ferric carboxymaltose developed hypophosphatemia (HPP). HPP occurs when the phosphate levels in the body begins to drop to a dangerous level. Phosphate keeps our bones and teeth healthy while also helping with energy production and nerve function. A sudden lack of phosphate can lead to serious injuries and, if left unchecked, death.
Another study found that 45.5% of the patients taking ferric carboxymaltose developed HPP, with 32% developing severe HPP. On average, it took patients 41 days to develop HPP after taking a ferric carboxymaltose injection, such as what is used in Injectafer.
What Are the Symptoms of HPP?
- Bone pain and fractures
- Coma
- Confusing
- Delirium
- Muscle Pain
- Seizures
- Death
What Do We Know About Injectafer Lawsuits?
The lawsuits against Injectafer are currently alleging that the manufacturers of Injectafer, American Regent, Inc., a subsidiary of Luipold Pharmaceuticals, Inc., knew or should have known of the HPP risks associated with Injectafer but did not adequately warn the public. The side effects listed as being “mild” are headaches, nausea and low levels of phosphorus in the blood. Many lawsuits point to the fact that the labeling fails to tell users and the health community of the varying degrees of severity of HPP that could occur after taking Injectafer.
One lawsuit has already been filed in the United States District Court for the Eastern District of Pennsylvania by a Virginia woman. The lawsuit alleges the use of Injectafer caused her to develop severe HPP. The plaintiff took the drug for the treatment of IDA a total of six (6) times. After her diagnosis, she was forced to undergo regular monitoring of her phosphorous levels. The lawsuit alleges eleven (11) courts, including strict liability, fraud, negligent design defect and gross negligence, to name a few.
Another lawsuit was also filed in the United States District Court for the Eastern District of Pennsylvania by a California man. The lawsuit raises similar allegations stating adverse and unexpected side effects as a result of taking the drug Injectafer. The man’s health became so bad that he had to be hospitalized for low phosphate levels. Even with aggressive treatment, his phosphate levels continue to be unstable.
Contact an Experienced Injectafer Lawyer!
If you or a loved one took Injectafer and were later diagnosed with severe HPP, you may be able to receive compensation for your lost earnings, medical bills and pain and suffering, among other losses. We work with experienced Injectafer lawyers across the nation who are ready to evaluate your case. Call us today toll-free 24/7 at 1-800-992-6878 or fill out an online contact form for a free (no obligation) case evaluation.